Evidence map›Paper›PMID 28884664›Full record

ArticleThe Journal of general virology2017

Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study.

Stanley Langevin, Maxime Pichon, Elise Smith, Juliet Morrison, Zachary Bent, Richard Green, Kristi Barker, Owen Solberg, Yves Gillet, Etienne Javouhey and 3 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of general virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Oral Cavity Microbiome Impact on Respiratory Infections Among Children.Pediatric health, medicine and therapeutics · 2024
    Review
  9. Characteristics of lower respiratory microbiota in children's refractoryFrontiers in cellular and infection microbiology · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Stanley LangevinDepartment of Microbiology, School of Medicine, University of Washington, Seattle, Washington, USA.
Maxime PichonLaboratoire de Virologie, IAI, CBN, Groupement Hospitalier Nord, Lyon, France.
Elise SmithDepartment of Microbiology, School of Medicine, University of Washington, Seattle, Washington, USA.
Juliet MorrisonDepartment of Microbiology, School of Medicine, University of Washington, Seattle, Washington, USA.
Zachary BentDepartment of Systems Biology, Sandia National Laboratories, Livermore, California, USA.
Richard GreenDepartment of Microbiology, School of Medicine, University of Washington, Seattle, Washington, USA.
Kristi BarkerDepartment of Microbiology, School of Medicine, University of Washington, Seattle, Washington, USA.
Owen SolbergDepartment of Systems Biology, Sandia National Laboratories, Livermore, California, USA.
Yves GilletDepartment of Pediatric Emergency, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Bron, France.
Etienne JavouheyDepartment of Pediatric Intensive Care, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Bron, France.
Bruno LinaUniversity Lyon, Virpath, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.
Michael G KatzeDepartment of Microbiology, School of Medicine, University of Washington, Seattle, Washington, USA.
Laurence JossetCentre National de Reference Virus Influenzae, IAI, CBN, Groupement Hospitalier Nord, Lyon, France.
University of Washington · USSandia National Laboratories California · USUniversité Claude Bernard Lyon 1 · FRHôpital Femme Mère Enfant · FR

Funding

NIAID NIH HHS HHSN272201400005C
6 · The paper itself

Abstract

A few studies have highlighted the importance of the respiratory microbiome in modulating the frequency and outcome of viral respiratory infections. However, there are insufficient data on the use of microbial signatures as prognostic biomarkers to predict respiratory disease outcomes. In this study, we aimed to evaluate whether specific bacterial community compositions in the nasopharynx of children at the time of hospitalization are associated with different influenza clinical outcomes. We utilized retrospective nasopharyngeal (NP) samples (n=36) collected at the time of hospital arrival from children who were infected with influenza virus and had been symptomatic for less than 2 days. Based on their clinical course, children were classified into two groups: patients with mild influenza, and patients with severe respiratory or neurological complications. We implemented custom 16S rRNA gene sequencing, metagenomic sequencing and computational analysis workflows to classify the bacteria present in NP specimens at the species level. We found that increased bacterial diversity in the nasopharynx of children was strongly associated with influenza severity. In addition, patients with severe influenza had decreased relative abundance of Staphylococcus aureus and increased abundance of Prevotella (including P. melaninogenica), Streptobacillus, Porphyromonas, Granulicatella (including G. elegans), Veillonella (including V. dispar), Fusobacterium and Haemophilus in their nasopharynx. This pilot study provides proof-of-concept data for the use of microbial signatures as prognostic biomarkers of influenza outcomes. Further large prospective cohort studies are needed to refine and validate the performance of such microbial signatures in clinical settings.

Indexed as

DysbiosisMicrobiotaBacteriaChildCluster AnalysisDNA, BacterialDNA, RibosomalHumansInfluenza, HumanNasopharynxPhylogenyPrognosisRetrospective StudiesRNA, Ribosomal, 16SSequence Analysis, DNADNA, BacterialDNA, RibosomalRNA, Ribosomal, 16Sbiomarkerchildrenemergency unitinfluenzaintensive caremicrobiome

Identifiers

PMID28884664
PMCPMC7011740
OpenAlexW2753339320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.